---
title: "Latest round of funding secured to boost clinical programmes for Topaz tricuspid valve system"
date: "2024-07-25T08:41:00.000Z"
publishedDate: "25 juillet 2024"
summary: "TRiCares SAS has announced it has raised US$50 million (€46 million) in a Series D financing round, with proceeds to support the upcoming US and EU clinical studies for the Topaz transfemoral tricuspid valve replacement system. The round was raised from a single, strategic investor."
importance: ""
sourceUrl: "https://cardiovascularnews.com/series-c-funding-tricares-topaz/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-07-25-latest-round-of-funding-secured-to-boost-clinical-programmes-for-topaz-tricuspid-valve-system"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/07/24.07.24-TRiCares-Topaz_Animation_Frame.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/series-c-funding-tricares-topaz/"
---

![Latest round of funding secured to boost clinical programmes for Topaz tricuspid valve system](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/07/24.07.24-TRiCares-Topaz_Animation_Frame.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/series-c-funding-tricares-topaz/*

## L’essentiel

TRiCares SAS has announced it has raised US$50 million (€46 million) in a Series D financing round, with proceeds to support the upcoming US and EU clinical studies for the Topaz transfemoral tricuspid valve replacement system. The round was raised from a single, strategic investor.

## Lien source

https://cardiovascularnews.com/series-c-funding-tricares-topaz/
